Surface Transforms management deliver positive operational update 16.09.2019 Watch Now

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,645.00
Bid: 1,645.00
Ask: 1,645.40
Change: -0.80 (-0.05%)
Spread: 0.40 (0.02%)
Open: 1,646.20
High: 1,651.00
Low: 1,639.60
Yest. Close: 1,645.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET PRE-OPEN: Glaxo Gets Positive Results From Zejula Study

Mon, 15th Jul 2019 07:40

(Alliance News) - Stock prices in London are seen opening slightly higher on Monday, tracking gains in Chinese equity markets despite a reported slowdown in economic growth there.In early UK company news, pharmaceutical company GlaxoSmithKline reported positive test results for one of its oncology drugs, Mike Ashley's Sports Direct delayed the release of its annual results, and Grainger secured funding for a big development in Leeds. IG futures indicate the FTSE 100 index is to open up 0.63 point at 7,506.60. The blue chip index closed 3.85 points lower, or 0.1%, at 7,505.97 on Friday.Drugmaker AstraZeneca said it has issued a complete response letter to the US Food & Drug Administration regarding the supplemental New Drug Application for diabetes treatment Farxiga. AstraZeneca said it will work with FDA on the next steps for Farxiga.Peer GlaxoSmithKline said it achieved positive results from the Phase 3 study of Zejula, for use for treatment of late-stage ovarian cancer. Glaxo said the study of its niraparib therapy - branded Zejula in the US and Europe - met the primary endpoint and produced statistically significant improvement in progression free survival."Almost 300,000 women around the world are diagnosed with ovarian cancer every year, yet only about 15% of patients are currently eligible to receive pharmacological inhibitors as their initial therapy. These exciting data demonstrate that Zejula has the potential to significantly benefit even more women with this devastating cancer," said Chief Scientific Officer Hal Barron.Sports Direct International said it will delay the release of its annual results, which were originally set for Thursday. The company said the reasons for the delay were due to the "complexities of the integration" of department store chain House of Fraser into the existing business and the current uncertainty regarding the future trading performance of that acquisition. As such, accounting firm Grant Thornton has asked for more time to complete its audit. Sports Direct said there are some "key areas to conclude" which could hurt the guidance given in December. The company now expects its audited results to be published between July 26 and August 23. Separately, Sports Direct said it has secured acceptances for 84% of video game retailer Game Digital's issued share capital. Residential landlord Grainger said it completed forward funding of a 216 home private rented sector development called Fabrik in Leeds for GBP34 million. Grainger said construction of the scheme, which has full planning consent, has recently started with completion expected in late 2021. The company expects the investment to generate a gross yield on cost of over 6.5% once stabilised. In China, the Shanghai Composite is up 0.4%, while the Hang Seng index in Hong Kong is up 0.1%. Financial markets in Japan are closed for the Marine Day public holiday.China's economy grew 6.2% in the second quarter of the year, the slowest pace since the government began publishing the data, in 1992.Economic growth slowed from 6.4% in the first three months of the year, the National Bureau of Statistics said Monday.The rate is still within the growth target set by the government for this year, of at least 6% growth, but it shows how the world's second-largest economy is being stymied by its trade war with the US. The sluggish manufacturing sector is largely responsible for the economic slowdown, with housing and consumption remaining resilient, experts say.In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.9%, S&P 500 up 0.5% and Nasdaq Composite up 0.6%.All three of Wall Street's main indices hit fresh record highs on Friday, ending the week on a strong note as investors grew increasingly confident the Federal Reserve will cut US interest rates at the end of the month. The S&P 500 closed above the 3,000-mark for the first time ever.The pound was quoted at USD1.2566 early Monday, firm against USD1.2554 at the London equities close Friday.Tory leadership contenders Boris Johnson and Jeremy Hunt will go head to head for what is expected to be the final time as the race for No 10 enters its closing stages.The two men will take part in a debate, hosted by The Sun and talkRadio, in front of a live studio audience in London on Monday in what could be the last chance to change the course of the battle to succeed Theresa May.Johnson remains the clear favourite to enter Downing Street on July 24 but supporters of Hunt believe that he is gaining ground.It had been thought that most of the ballot papers from the party's 180,000 grassroots members would have been returned by this stage of the contest.However reports suggest the votes have been coming in more slowly than expected, suggesting many members have been keen to see how the two candidates perform in the campaign before making up their minds.There are no major events remaining in the economic calendar on Monday after the release of the Chinese data.

More News

BROKER RATINGS SUMMARY: Morgan Stanley Raises SSE To Overweight

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:----------FTSE 100----------DEUTSCHE BANK RAISES RENTOKIL INITIAL

10 Sep 19 09:32

Aurora Investment Trust Net Assets Rise But Total Interim Return Lags

(Alliance News) - Aurora Investment Trust PLC on Monday said its net asset value rose in the first six months of the year but total return lagged behind its benchmark index.At June 30, a of

9 Sep 19 12:12

BROKER RATINGS SUMMARY: Deutsche Bank Raises BHP And Cuts Antofagasta

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:----------FTSE 100----------DEUTSCHE BANK RAISES BHP

4 Sep 19 09:32

Tuesday broker round-up

(Sharecast News) - easyJet: Kepler Cheuvreux downgrades to reduce with a target price of 820p.

3 Sep 19 12:59

BROKER RATINGS SUMMARY: Deutsche Bank Starts Taylor Wimpey At Buy

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:----------FTSE 100----------DEUTSCHE BANK INITIATES TAYLOR WIMPEY

3 Sep 19 09:40

LONDON MARKET OPEN: Ferguson-Wolseley Rises; Pound Falls Below USD1.20

(Alliance News) - Stock prices in London opened mixed on Tuesday, with Ferguson the best blue-chip performer after the company decided to split its UK and US operations, while the pound fell below

3 Sep 19 08:49

Monday broker round-up

(Sharecast News) - Beazley: UBS upgrades to buy with a target price of 650p.

2 Sep 19 13:16

Former Glaxo Vice President To Lead C4X Discovery Advisory Network

(Alliance News) - C4X Discovery Holdings PLC on Monday said it is forming a drug discovery advisory network chaired by "renowned industry veteran" Robin Carr.Shares in C4X were up

2 Sep 19 12:02

BROKER RATINGS SUMMARY: Goldman Sachs Says Buy Unilever, Sell M&S

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday afternoon:----------FTSE 100----------GOLDMAN SACHS WITH

2 Sep 19 09:41

BROKER RATINGS SUMMARY: UBS Raises Greggs; Peel Hunt Lifts Chesnara

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday afternoon and Wednesday morning:----------FTSE 100----------KEPLER RAISES

28 Aug 19 09:37

GlaxoSmithKline's Dreamm-2 Multiple Myeloma Trial Results Encouraging

(Alliance News) - GlaxoSmithKline PLC on Friday reported positive headline results from its Dreamm-2 study of belantamab mafodotin in multiple myeloma.The study, which involved 196 patients

23 Aug 19 07:46

GlaxoSmithKline reveals positive results from belantamab mafodotin trial

(Sharecast News) - GlaxoSmithKline announced positive headline results from the pivotal 'DREAMM-2' open-label, randomised study of two doses of belantamab mafodotin on Friday.

23 Aug 19 07:29

Glaxo's ViiV Reports Positive Study Results Of HIV-Treatment Regimen

(Alliance News) - GlaxoSmithKline PLC on Thursday said ViiV Healthcare reported positive headline results from its global phase III ATLAS-2M study.ViiV Healthcare is a specialist HIV owned

22 Aug 19 08:20

GlaxoSmithKline upbeat on latest test results from ViiV Healthcare

(Sharecast News) - GlaxoSmithKline reported on Thursday that its specialist HIV company ViiV Healthcare had announced positive headline results from its phase 3 'ATLAS-2M' study of the investigational, long-acting, injectable, two-drug regimen (2DR) of its cabotegravir and Janssen's rilpivirine for the treatment of HIV.

22 Aug 19 07:29

Glaxo Submits Japanese Application For Daprodustat Anaemia Drug

(Alliance News) - GlaxoSmithKline PLC on Wednesday said it has submitted a new drug application in Japan for anaemia drug daprodustat.The application was submitted to the Japanese Ministry

21 Aug 19 08:38

Login to your account

Don't have an account? Click here to register.